Project Description

Amyndas Pharmaceuticals is a fast-developing innovator and emerging leader in the field of “complement therapeutics” developing advanced therapies to treat several human diseases including paroxysmal nocturnal hemoglobinuria, age-related macular degeneration, chronic inflammation during hemodialysis, ischemia-reperfusion injury and graph rejections.